ABB India win orders worth Rs 191 crore
ABB India win orders worth Rs 191 crore

ABB India win orders worth Rs 191 crore

Anthony Fernandes Article rating: 4.1

ABB India announced that it has bagged two significant orders, one to supply traction equipment for Chittaranjan Locomotive Works (CLW), the manufacturing unit of the Indian Railways and another to supply industrial drives to Megha Engineering and Infrastructures Limited (MEIL) in their oil drilling segment. The said orders are worth Rs 123 crore and Rs 68 crore, respectively.

IRB shares down despite chances of winning toll rights
IRB shares down despite chances of winning toll rights

IRB shares down despite chances of winning toll rights

Avalokita Pandey Article rating: 3.7

The shares of IRB Infrastructure Developers Limited, an Indian highway construction company, fell over by two per cent on Wednesday despite that the company is all set to win a contract for the operation and collection of toll at Mumbai-Pune Expressway for 10 years.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.1

The market opened in the green on February 12, 2020, overall volumes in futures & options currently stand at 1.57 crore contracts with a turnover of Rs. 11,40,798.72 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 3.8

The market opened in the green on February 12, 2020, overall volumes in futures & options currently stand at 1.57 crore contracts with a turnover of Rs. 11,40,798.72 crore.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.3

The market opened in the green on February 12, 2020. The previous trading session witnessed the Sensex going up by 236.52 points to end at 41,216.14 and the Nifty was up by 76.40 points to close at 12,107.90

SPARC dips on getting CRL from USFDA for Taclantis
SPARC dips on getting CRL from USFDA for Taclantis

SPARC dips on getting CRL from USFDA for Taclantis

Apurva Joshi Article rating: 4.0

Sun Pharma Advanced Research Company Limited (SPARC), on Tuesday, said that United States Food & Drug Administration (USFDA) has not approved its New Drug Application (NDA) for Taclantis, a product used for treating breast cancer.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 3.9

The market opened in the green on February 12, 2020. The previous trading session witnessed the Sensex going up by 236.52 points to end at 41,216.14 and the Nifty was up by 76.40 points to close at 12,107.90

Index trend and stocks in action on February 12, 2020
Index trend and stocks in action on February 12, 2020

Index trend and stocks in action on February 12, 2020

Karan Dsij Article rating: 3.8

The bulls are expected to witness a momentum on the upside, only if they manage to convincingly close above the 50-DMA and stays above that level for a couple of days. In any case, Nifty closes below the prior bar low or gravestone doji low of 12,099, which could be the first sign of weakness. 

SGX indicates positive opening on cards
SGX indicates positive opening on cards

SGX indicates positive opening on cards

Karan Dsij Article rating: 4.0

Indian markets are likely to open a tad higher on Wednesday as sentiments amongst the Asian peers are seen upbeat on hopes as the spread of coronavirus is slowing down. SGX Nifty is trading up by 33 points at 12,160 levels.

NFO update: Sundaram Balanced Advantage Fund

NFO update: Sundaram Balanced Advantage Fund

Shashikant Singh Article rating: 3.8

Sundaram Mutual has announced the launch of its new open-ended equity scheme, Sundaram Balanced Advantage Fund. ​ The New Fund Offer opens for subscription on February 14, 2020, and closes on February 28, 2020.

RSS
First22532254225522562258226022612262Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR